Clinical Trials Logo

Clinical Trial Summary

Hematoma is a common complication of bilateral breast reduction (BBR) surgery. This can lead to pain and discomfort experienced by the patient, in addition to greater use of valuable healthcare resources. Previous studies have shown correlation between the use of tranexamic acid (TXA), an anti-fibrinolytic, and reduced post-surgical bleeding complication events. In this randomized control trial (RCT) evaluation TXA use in BBR, for which one breast will be randomized to have TXA applied topically, while the other will have normal saline (NS) placebo applied. The primary objective of this prospective blinded randomized control trial study is to determine if the administration of topical TXA in BBR reduces the incidence of surgical site hematoma compared to placebo within 2 weeks following surgery. The results of this study will be used to inform the design of a larger multicentered RCT on TXA in breast surgery.


Clinical Trial Description

The primary objective of this study is to investigate the use of topical application of tranexamic Acid (TXA) to the surgical wound as a means to decrease hematoma formation compared to placebo in patients undergoing bilateral breast reduction (BBR). This project is designed as a single-center RCT to evaluate the effectiveness of topical TXA in this patient population. If enrolled in this study, patients individual breasts will be randomly assigned to one of two treatment groups for to apply to the wound before it is closed. One breast will have an intravenous form of TXA applied topically to the surgical site. The other will be have a topical normal saline solution applied to the wound before closure (a placebo). The patients will have the standard number of drains and postoperative instructions for breast reduction. They will follow-up at two weeks time in clinic for assessment, and emergency room visits will be also be evaluated. Standard of care will be practiced with respect to all procedures and visits. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04918576
Study type Interventional
Source McMaster University
Contact Yaeesh Sardiwalla, MD
Phone 90505221155
Email yaeesh.sardiwalla@medportal.ca
Status Not yet recruiting
Phase Phase 3
Start date August 2022
Completion date August 2024

See also
  Status Clinical Trial Phase
Completed NCT06280456 - Tranexamic Acid Injection With Different Drainage Clamping Time After Anterior Cruciate Ligament Reconstruction N/A
Recruiting NCT06067217 - Comparative Study of Tranexamic Acid, Estrogen for Treatment AUB in DMPA Users N/A
Completed NCT03113253 - TRANexamic Acid to Reduce Bleeding in BURN Surgery Phase 4
Completed NCT02903017 - Local Administration of Tranexamic Acid in Upper Gastrointestinal Hemorrhage Phase 4
Completed NCT02569658 - Investigation of Intravenous Tranexamic Acid With Anatomic and Reverse Total Shoulder Arthroplasty N/A
Terminated NCT03085394 - Preoperative Hexakapron Reduces Bleeding in Bariatric Surgery Phase 3
Completed NCT04911413 - Comparison of Three Tranexamic Acid Dose Regimens in Patients Undergoing Cardiac Valve Surgery Phase 4
Recruiting NCT02938962 - Intravenous vs. Topical Tranexamic Acid in Revision THA (VITALITY-X) Phase 4
Completed NCT01895101 - The Effect on Blood Loss of Topical and Intravenous Tranexamic Acid in Cardiac Surgery Patients Phase 4
Completed NCT02806024 - Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study Phase 4
Completed NCT03897621 - The Effect of Tranexamic Acid on Blood Coagulation in Total Hip Arthroplasty Surgery N/A
Completed NCT03360045 - Comparing Effectiveness of Merocel and Packing With Tranexamic Acid in the Management of Anterior Epistaxis Phase 4
Completed NCT06301204 - Effectiveness Of Tranexamic Acıd Application Wıth Different Doses On Bleeding, Edema And Physician Comfort In Orthognathıc Surgery Patients N/A
Completed NCT04025736 - Arthroscopic Shoulder Surgery With Administration of Intravenous Tranexamic Acid N/A
Completed NCT04427618 - Tranexamic Acid in the Prevention of Postpartum Hemorrhage in Elective Caesarean Section Phase 3
Not yet recruiting NCT05913466 - Intraprostatic Injection of Tranexamic Acid Decrease Blood Loss During Monopolar TURP N/A
Recruiting NCT05230381 - Intravenous Tranexamic Acid Reducing Intraoperative Blood Loss in Huge Meningiomas Resection N/A
Completed NCT01980355 - TXA Study in Major Oncologic Surgery N/A
Not yet recruiting NCT06010368 - Comparing Intramyometrial Tranexamic Acid and Oxytocin for Blood Loss in Cesarean Section Phase 3
Withdrawn NCT03433144 - The Effects of Tranexamic Acid on Blood Loss During Orthognathic Surgery Phase 4